Artificial protein has passed the test.
The team led by Professor Olivier George of the research Institute of SCRIPPS was able to develop an artificial enzyme, which has the potential to degrade the nicotine supplied to the human body.
This will reduce cravings for the substance and monitor its level in the blood. An article published in the journal Science Advances.
Artificial protein called NicA2-J1 was successfully tested on lab rats, accustomed to the nicotine consumption.
Olivier George noted that a new approach to the withdrawal from nicotine is additionally interesting because it allows to avoid unpleasant withdrawal symptoms.
In addition, the ability of the drug to work in blood but not in brain, significantly reduces the chance of developing any side effects after ingestion.
© 2018, z-news.link. All rights reserved.